I see EOF as the next A2M, if the sales can grow at the same rate. from a few million per year in 2017 to 13million per half year in 2018 to 10million per quarter is a huge growth.
also, there will be a small profit in 2019, if growth continues, it might be a big profit next year.
also, this is only based on one product health part, what if the other 2 parts got progressed.
Ann: Appendix 4C - quarterly, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EOF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.53M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 154546 | 2 |
View Market Depth
| Last trade - 15.08pm 15/07/2024 (20 minute delay) ? |
| EOF (ASX) Chart |
Day chart unavailable